Market Tracker

04/28 5:16pm ET

Abbott Laboratories (NYSE:ABT)

43.64
Delayed Data
As of Apr 28
 -0.01 / -0.02%
Today’s Change
36.76
Today|||52-Week Range
45.84
+13.62%
Year-to-Date

Today’s Trading

Previous close43.65
Today’s open43.67
Day’s range43.50 - 43.75
Volume6,014,062
Average volume (3 months)8,200,237
Market cap$75.4B
Dividend yield2.43%
Data as of 4:01pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)-47.25%
Earnings growth (this year)+12.42%
Earnings growth (next 5 years)+10.95%
Revenue growth (last year)+2.20%
P/E ratio61.5
Price/Sales2.73
Price/Book3.13

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca-0.61-1.98%
NVONovo Nordisk-0.10-0.26%
AGNAllergan+0.81+0.33%
LLYEli Lilly and Co+0.73+0.90%
Data as of 4:03pm ET, 04/28/2017

Financials

Next reporting dateJuly 19, 2017
EPS forecast (this quarter)$0.60
Annual revenue (last year)$20.9B
Annual profit (last year)$1.4B
Net profit margin5.06%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Miles D. White
Chief Financial Officer &
Executive VP-Finance
Brian B. Yoor
Corporate headquarters
Abbott Park, Illinois

Forecasts